Treasurer of the State of North Carolina’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18M Buy
54,269
+1,155
+2% +$393K 0.06% 293
2025
Q4
$21.1M Sell
53,114
-3,009
-5% -$1.33M 0.07% 246
2025
Q3
$25.6M Sell
56,123
-2,181
-4% -$888K 0.08% 220
2025
Q2
$19M Sell
58,304
-651
-1% -$180K 0.06% 292
2025
Q1
$15.9M Sell
58,955
-27,960
-32% -$7.19M 0.06% 266
2024
Q4
$20.5M Buy
86,915
+2,310
+3% +$608K 0.08% 228
2024
Q3
$23.3M Buy
84,605
+5,040
+6% +$1.31M 0.09% 200
2024
Q2
$19.3M Sell
79,565
-7,822
-9% -$1.23M 0.08% 215
2024
Q1
$13.1M Buy
87,387
+690
+0.8% +$115K 0.06% 311
2023
Q4
$16.6M Buy
86,697
+740
+0.9% +$126K 0.08% 245
2023
Q3
$15.2M Sell
85,957
-960
-1% -$183K 0.08% 246
2023
Q2
$16.5M Sell
86,917
-1,560
-2% -$309K 0.09% 228
2023
Q1
$17.7M Buy
88,477
+2,110
+2% +$444K 0.1% 205
2022
Q4
$20.5M Buy
86,367
+1,880
+2% +$401K 0.13% 170
2022
Q3
$16.9M Buy
84,487
+500
+0.6% +$95.4K 0.11% 180
2022
Q2
$12.3M Buy
83,987
+6,428
+8% +$912K 0.08% 253
2022
Q1
$12.7M Buy
77,559
+1,775
+2% +$270K 0.07% 260
2021
Q4
$12.9M Sell
75,784
-520
-0.7% -$96.6K 0.07% 273
2021
Q3
$14.4M Buy
76,304
+3,329
+5% +$624K 0.08% 224
2021
Q2
$12.4M Buy
72,975
+1,010
+1% +$148K 0.07% 250
2021
Q1
$10.2M Sell
71,965
-587
-0.8% -$88.3K 0.06% 288
2020
Q4
$9.43M Buy
72,552
+1,100
+2% +$147K 0.06% 297
2020
Q3
$10.4M Buy
71,452
+4,250
+6% +$604K 0.08% 232
2020
Q2
$9.95M Buy
67,202
+13,385
+25% +$1.8M 0.08% 220
2020
Q1
$5.86M Buy
53,817
+18,910
+54% +$2.18M 0.05% 316
2019
Q4
$4.02M Sell
34,907
-6,340
-15% -$632K 0.03% 368
2019
Q3
$3.32M Sell
41,247
-23,663
-36% -$1.87M 0.03% 410
2019
Q2
$4.71M Sell
64,910
-665
-1% -$51K 0.03% 491
2019
Q1
$6.13M Buy
65,575
+1,510
+2% +$126K 0.04% 391
2018
Q4
$4.67M Buy
64,065
+1,137
+2% +$87.5K 0.03% 434
2018
Q3
$5.51M Buy
62,928
+41,856
+199% +$4.21M 0.03% 435
2018
Q2
$2.08M Buy
21,072
+11,826
+128% +$1.17M 0.02% 574
2018
Q1
$1.1M Buy
+9,246
New +$1.19M 0.03% 547

Other funds holding ALNY